Entourage Health Corp. (formerly WeedMD Inc.)
(
TSX-V:ENTG)
(OTCQX:WDDMF)
(FSE:4WE) (“
Entourage” or the
“
Company”), a Canadian producer and distributor of
cannabis products and brands, is pleased to announce its
adult-use brand Saturday Cannabis is now available for purchase in
the Province of Quebec. Following the completion of its first
shipment of Saturday’s Lemon Z and Ultra Sour dried flower
cultivars to the Société québécoise du cannabis (“SQDC”), Entourage
now has over 10 product listing in the province, which are being
distributed locally via Quebec-based cultivator and local partner
ROSE LifeScience Inc. (“ROSE”).
The Saturday line up joins the Company’s Color
Cannabis’ portfolio of expansive products available in cultivars
Pedro’s Sweet Sativa, Ghost Train Haze, Mango Haze and Black Sugar
Rose in both dried flower and pre-roll formats.
“We continue to see rapid and impressive growth
in the Province of Quebec – where sales and order fulfilments have
contributed greatly to the success we’ve seen in the first half of
the year,” said Joseph Mele, SVP, Commercial, Sales and Marketing,
Entourage Health. “Our products are taking top billing at many
provincial retail outlets due to our consistent ability to deliver
quality-produced cannabis and in the case of Quebec, we’re doing so
alongside the very talented team of marketing and distribution
professionals at ROSE LifeScience.”
"In just a few short months, we’ve diversified
our product listing in Quebec to include access to the Saturday
Cannabis product line and more selection of Color Cannabis
cultivars and products,” said Davide Zaffino, President and Chief
Financial Officer, ROSE LifeScience. “Ensuring our province has
access to consistent products from producers like Entourage Health
is an important step in continuously elevating the cannabis
industry locally and across Canada."
Visit Entourage Health’s newly launched website
here. To access our corporate video, visit us here and to access
our latest investor presentation and corporate deck here.
About ROSE LifeScience
Inc.As a private Quebec company, founded by a group of
seasoned executives with extensive experience in highly regulated
industries, ROSE LifeScience is committed to ensuring that Quebec
benefits from the responsible production, sale and use of cannabis.
From cannabis cultivation to marketing and logistics, ROSE plays a
key role in the Quebec market. ROSE not only produces remarkable
cannabis, but also offers complete marketing services to selected
producers to encourage diversified offerings in the Quebec
market.
About Entourage Health
Corp.
Entourage Health Corp. (formerly WeedMD Inc.) is
the publicly traded parent company of WeedMD RX Inc., a licence
holder producing and distributing cannabis products for both the
medical and adult-use markets. The Company owns and operates a
158-acre state-of-the-art greenhouse, outdoor and processing
facility located in Strathroy, ON as well as a fully-licensed
26,000 sq. ft. Aylmer, ON processing facility, specializing in
cannabis extraction. With the addition of Starseed Medicinal, a
medical-centric brand, Entourage has expanded its multi-channeled
distribution strategy. Starseed’s industry-first, exclusive
partnership with LiUNA, the largest construction union in Canada,
along with employers and union groups complements Entourage’s
direct sales to medical patients. In July 2021, Entourage signed a
definitive agreement to acquire craft cultivator CannTx Life
Sciences Inc. which operates out of its state-of-the-art
micropropagation and specialty extraction facility in Guelph,
Ontario. Upon the expected closing in late August 2021, craft brand
Royal City Cannabis will be added to Entourage’s elite product
portfolio. The Company maintains strategic relationships in the
seniors’ market and supply agreements with Shoppers Drug Mart as
well as eight provincial distribution agencies where adult-use
brands Color Cannabis and Saturday Cannabis are sold. Entourage is
also the exclusive Canadian producer and distributor of
award-winning U.S.-based wellness brand Mary’s Medicinals sold in
both medical and adult-use channels.
For more information, please visit us at
www.entouragehealthcorp.com
Follow Entourage and its brands on
LinkedIn
Twitter: Entourage,
Color Cannabis, Saturday
Cannabis &
Starseed
Instagram: Color
Cannabis, Saturday
Cannabis &
Starseed
For further information, please
contact:
For Investor Enquiries:Valter
PintoManaging Director KCSA Strategic
Communications1-212-896-1254entourage@kcsa.com
For Media Enquiries:Marianella
delaBarreraSVP, Communications & Corporate
Affairs416-897-6644marianella@weedmd.com
Forward Looking Information
This press release contains "forward-looking information" within
the meaning of applicable Canadian securities legislation which are
based upon Entourage's current internal expectations, estimates,
projections, assumptions and beliefs and views of future events.
Forward-looking information can be identified by the use of
forward-looking terminology such as "expect", "likely", "may",
"will", "should", "intend", "anticipate", "potential", "proposed",
"estimate" and other similar words, including negative and
grammatical variations thereof, or statements that certain events
or conditions "may", "would" or "will" happen, or by discussions of
strategy.
The forward-looking information in this news
release is based upon the expectations, estimates, projections,
assumptions and views of future events which management believes to
be reasonable in the circumstances. Forward-looking information
includes estimates, plans, expectations, opinions, forecasts,
projections, targets, guidance or other statements that are not
statements of fact. Forward-looking information necessarily involve
known and unknown risks, including, without limitation, risks
associated with general economic conditions; adverse industry
events; loss of markets; future legislative and regulatory
developments; inability to access sufficient capital from internal
and external sources, and/or inability to access sufficient capital
on favourable terms; the cannabis industry
in Canada generally; the ability of Entourage to
implement its business strategies; the COVID-19 pandemic;
competition; crop failure; and other risks.
Any forward-looking information speaks only as
of the date on which it is made, and, except as required by law,
Entourage does not undertake any obligation to update or revise any
forward-looking information, whether as a result of new
information, future events or otherwise. New factors emerge from
time to time, and it is not possible for Entourage to predict all
such factors. When considering this forward-looking information,
readers should keep in mind the risk factors and other cautionary
statements in Entourage’s disclosure documents filed with the
applicable Canadian securities regulatory authorities on SEDAR at
www.sedar.com. The risk factors and other factors noted in the
disclosure documents could cause actual events or results to differ
materially from those described in any forward-looking
information.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS
REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE
POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS RELEASE
Entourage Health (TSXV:ENTG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Entourage Health (TSXV:ENTG)
Historical Stock Chart
From Jul 2023 to Jul 2024